+1 (202) 780-3397
2021: Volume 4, Issue 4
Abstract P.1-2
Novel technologies can successfully activate positive behaviors of stakeholders involved in vaccine purchasing and usage
Author(s): Pierre A Morgon
Abstract P.1-2
Application of the theory of planned behavior to vaccination of dogs against rabies in Abeokuta Ogun State, Nigeria
Author(s): Awoyomi Olajoju J
Abstract P.1-2
Analyzing a decade of childhood vaccination and timeliness by deprivation in NHS Lothian
Author(s): Eram Ali Haider
Abstract P.1-2
Recombinant approach to develop ScFv antibodies and vaccines against viral diseases as Ebola, flu (AH1N1) and cancer (polyomavirus)
Author(s): Luis Mario Rodriguez-Martinez
Abstract P.1-3
The therapeutic P140 peptide, a new immunomodulating tool for lupus may have applications in other chronic inflammatory conditions
Author(s): Sylviane Muller
Abstract P.1-1
Dapirolizumab pegol: A novel treatment of patients with SLE by inhibiting CD40L
Author(s): Farnaz Fallah-Arani,
Abstract P.1-2
Type 1 Diabetes: Prediction and progression
Author(s): K M Gillespie, A E Long, I Wilson Karolinska University Hospital Huddinge, Sweden
Abstract P.1-2
The autoimmune and immunodeficiency manifestations of ACP5 mutations
Author(s): Tracy Briggs, Gillian I Rice, Brigitte Bader-Meunier and Yanick J Crow
Abstract P.1-2
Quadrivalent and nonavalent HPV vaccine :Ovarian safety research.
Author(s): Deirdre Little